Abstract
Viral infections are frequently associated with haematological disorders (reviewed in ref. 1). Abnormalities including leukopenia, anaemia and thrombocytopenia are commonly observed in patients with the acquired immune deficiency syndrome (AIDS) or the AIDS-related complex (ARC)2–12. The underlying cause of these haematological abnormalities is poorly understood. We report here that bone marrow progenitors isolated from AIDS or ARC patients are responsive to recombinant human granulocyte-macrophage colony stimulating factor (rGM-CSF) and recombinant erythropoietin. Antibodies present in the serum of patients infected with the human immunodeficiency virus (HIV), however, could suppress the growth of these progenitors, but not the growth of progenitors from HIV seronegative controls. A component of this immune-mediated suppression appears to be antibodies directed towards the envelope glycoprotein (gp120) of HIV.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Young, N. & Mortimer, P. Blood 63, 729–737 (1984).
Abrams, D. I. et al. Am. J. clin. Path. 81, 13–18 (1984).
Spivak, J. L., Bender, B. S. & Quinn, T. C. Am. J. Med. 77, 224–228 (1984).
Schneider, D. R. & Picker, L. J. Am. J. clin. Path. 84, 144–52 (1985).
Castella, A., Croxson, T. S., Mildvan, D., Witt, D. H. & Zalunsky, R. Am. J. clin. Path. 84, 425–32 (1985).
Geller, S. A., Muller, R., Greenberg, M. L. & Siegal, F. P. Archs Path. 109, 138–141 (1985).
Zon, L. I., Arkin, C. & Groopman, J. E. Br. J. Haemat. (in the press).
Morris, L. et al. Ann. Intern. Med. 96, 714–717 (1982).
Walsh, C., Nardi, M. & Karpatkin, S. New Engl. J. Med. 311, 635–639 (1984).
Stricker, R. B., Abrams, D. I., Corash, L. & Shuman, M. A. N. Engl. J. Med. 313, 1375–1380 (1985).
Murphy, M. F. et al. Lancet i, 217–218 (1985).
Leiderman, I. Z., Greenberg, M. L., Adelsberg, B. R. & Siegal, F. P. in AIDS (eds Gottlieb, M. S. & Groopman, J. E.) 281–289 (Liss, New York, 1984).
Barre-Sinoussi, F. et al. Science 220, 868–871 (1983).
Gallo, R. C. et al. Science 224, 500–503 (1984).
Hammer, S. N., Gillis, J., Groopman, J. E. & Rose, R. M. Proc. natn. Acad. Sci. U.S.A. 83, 8734–8738 (1986).
Busch, M., Beckstead, J., Gantz, D. & Vyas, G. Blood 68, 122a (1986).
Armstrong, J. A. & Horne, R. Lancet ii, 370–372 (1984).
Gartner, S. et al. Science 233, 215–219 (1986).
Gyorkey, F., Melnick, J. L., Sinkovics, J. G. & Gyorkey, P. Lancet i, 106 (1985).
Koenig, S. et al. Science 233, 1089–1093 (1986).
Salahuddin, S. Z., Rose, R. M., Groopman, J. E., Makham, P. D. & Gallo, R. C. Blood 68, 281–284 (1986).
Ho, D. D. Rota, T. R. & Hirsch, M. S. J. clin. Invest. 77, 1712–1715 (1986).
Gartner, S. et al. Science 233, 215–219 (1986).
Levy, J. A. et al. Virology 147, 441–448 (1985).
Nicholson, J. K. A., Cross, G. D., Callaway, C. S. & McDougal, J. S. J. Immun. 137, 323–329 (1986).
Cortes, E., Koeffler, H. P., Gaynor, R. & Mitsuyasu, R. Blood 68, 123a (1986).
Lasky, L. A. et al. Science 233, 209–212 (1986).
Metcalf, D. Int. J. Cancer 27, 577–584 (1981).
Hall, B. M. Br. J. Haemat. 17, 553–561 (1969).
Morley, A., Quesenberry, P., Bealmear, P., Stohlman, F. & Wilson, R. Proc. Soc. exp. Biol. Med. 140, 478–480 (1972).
Murray, H. W., Rubin, B. Y., Masur, H. & Roberts, R. B. New Engl. J. Med. 310, 883–884 (1984).
Cunningham Rundles, S., Michelis, M. A. & Masur, H. J. clin. Immun. 3, 156–165 (1983).
Laurence, J., Gottlieb, A. B. & Kunkel, H. G. J. clin. Invest. 72, 2072–2081 (1983).
Chervenick, P. A. & LoBuglio, A. F. Science 178, 164–166 (1972).
Dinarello, C. A. Rev. infect. Dis. 6, 51–95 (1984).
Zucali, J. R. et al. J. clin. Invest. 77, 1857–1863 (1986).
Donahue, R. et al. Nature 321, 872–875 (1986).
Wong, G. G. et al. Science 228, 810–815 (1985).
Wong, G. G. et al. in Cancer Cells Vol. 3 (eds Feramisco, J., Ozanne, B. & Stiles, C.) 235–241 (Cold Spring Harbor Laboratory, New York, 1985).
Jacobs, K. et al. Nature 313, 806–810 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donahue, R., Johnson, M., Zon, L. et al. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature 326, 200–203 (1987). https://doi.org/10.1038/326200a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/326200a0
This article is cited by
-
HIV infection: focus on the innate immune cells
Immunologic Research (2016)
-
Preferential depletion of CD2low plasmacytoid dendritic cells in HIV-infected subjects
Cellular & Molecular Immunology (2011)
-
Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells
Archives of Virology (1994)
-
Implications of HIV specific cytotoxic T lymphocytes in AIDS
Biotherapy (1992)
-
Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells
Archives of Virology (1992)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.